Abstract: The present invention relates to a dendrite elongation inhibitor for melanocytes consisting of a compound represented by the following general formula (1): and/or a salt thereof, wherein R1, R2, and R3 each independently represent a C1-4 alkyl group or hydrogen atom, and a skin preparation for external use comprising the dendrite elongation inhibitor for melanocytes as an active ingredient.
Type:
Grant
Filed:
November 28, 2003
Date of Patent:
November 28, 2006
Assignee:
Pola Chemiocal Industries Inc.
Inventors:
Akihiro Tada, Akiko Kanamaru, Yuko Saeki